Literature DB >> 3918684

Effect of long term hormone replacement on plasma prolactin concentrations in women after oophorectomy.

D H Barlow, G H Beastall, H I Abdalla, J Elias-Jones, R Lindsay, D M Hart.   

Abstract

Plasma prolactin concentrations were studied in 88 oophorectomised women who had been receiving mestranol or placebo for three to 11 years. Thirty one of them were also studied under basal conditions and by tests with thyrotrophin releasing hormone. Under basal conditions the mean prolactin concentration was higher in the oestrogen treated group but under non-rested, clinic conditions the difference was lost because of a rise in prolactin value in the placebo group only. Hence the groups showed a different prolactin response to the mild stress of clinic attendance but the same proportionate responsiveness to thyrotrophin releasing hormone. The data suggest that long term hormone replacement has no significant effect on circulating prolactin concentrations under non-rested, everyday conditions and that the prolactin stimulating effects of minor stress and oestrogen may share a similar mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918684      PMCID: PMC1417321          DOI: 10.1136/bmj.290.6468.589

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  17 in total

1.  Laboratory assessment of prolactin status.

Authors:  E A Cowden; W A Ratcliffe; G H Beastall; J G Ratcliffe
Journal:  Ann Clin Biochem       Date:  1979-05       Impact factor: 2.057

2.  Oral contraceptive agents do not affect serum prolactin in normal women.

Authors:  J R Davis; C Selby; W J Jeffcoate
Journal:  Clin Endocrinol (Oxf)       Date:  1984-04       Impact factor: 3.478

3.  Oral contraceptives and pituitary adenomas.

Authors:  S J Wingrave; C R Kay; M P Vessey
Journal:  Br Med J       Date:  1980-03-08

4.  Post-"pill" amenorrhoea--cause or coincidence?

Authors:  H S Jacobs; U A Knuth; M G Hull; S Franks
Journal:  Br Med J       Date:  1977-10-08

5.  Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy.

Authors:  T Lind; E H Cameron; W M Hunter
Journal:  Br J Obstet Gynaecol       Date:  1978-02

6.  Breast cancer and estrogen replacement therapy.

Authors:  B S Hulka; L E Chambless; D C Deubner; W E Wilkinson
Journal:  Am J Obstet Gynecol       Date:  1982-07-15       Impact factor: 8.661

7.  Decreased incidence of breast cancer in postmenopausal estrogen-progestogen users.

Authors:  R D Gambrell; R C Maier; B I Sanders
Journal:  Obstet Gynecol       Date:  1983-10       Impact factor: 7.661

8.  Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.

Authors:  M C Pike; B E Henderson; M D Krailo; A Duke; S Roy
Journal:  Lancet       Date:  1983-10-22       Impact factor: 79.321

9.  Pathogenesis of prolactin-secreting pituitary adenomas.

Authors:  B M Sherman; C E Harris; J Schlechte; T M Duello; N S Halmi; J VanGilder; F K Chapler; D K Granner
Journal:  Lancet       Date:  1978-11-11       Impact factor: 79.321

10.  Lack of effect of interview and gynaecological examination on plasma levels of prolactin and cortisol.

Authors:  J M Pearce; G McGarrick; G V Chamberlain; S L Jeffcoate
Journal:  Br J Obstet Gynaecol       Date:  1980-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.